AstraZeneca (AZN) stock is trading at GBX12,766, reflecting a decline of 1.65% on the day. The price is positioned above its key short- and medium-term moving averages, ...
Late-stage trial results suggest Amgen may strengthen Imdelltra's commercial prospects in small cell lung cancer by pairing it with AstraZeneca's Imfinzi. The study shows the combination cuts the ...
AstraZeneca (AZN) stock is trading at GBX12,928, up 2.49% for the session. The price is holding above its key short- and medium-term moving averages, reflecting broad ...
AstraZeneca will provide its nine-month and third-quarter 2026 performance update to investors on 30 October. The stock is up 2.4% on the day at GBX12,928.AstraZeneca will release its nine-month ...
AstraZeneca (AZN) stock is trading at GBX12,626, showing a marginal gain on the day and continuing to hold above its key short- and medium-term moving averages while ...
AstraZeneca (AZN) stock is trading at GBX12,586 today, marking a 1.5% gain for the session and opening with a 40-point up gap. The price remains above its short- and ...
AstraZeneca (AZN) stock is trading at GBX12,390 today, reflecting a slight decline for the session. The price is currently positioned below its key short-term averages ...
AstraZeneca (AZN) stock is trading at GBX12,430, down 2.11% on the day. The share price is currently positioned below its key short- and long-term moving averages but ...
AstraZeneca (AZN) stock is trading at GBX12,698, up 3.24% on the day. Shares are positioned above their key short- and medium-term moving averages, suggesting near-term ...
AstraZeneca is expanding its use of artificial intelligence in early-stage research through a new collaboration with insitro focused on hard-to-treat liver and heart diseases. The agreement ...
AstraZeneca (AZN) stock is trading at GBX12,320, up 3.56% on the day. The shares are positioned above their key short- and medium-term moving averages, reflecting ...
AstraZeneca (AZN) stock is trading at GBX11,906 after slipping modestly on the day. The shares are positioned below their key moving averages, reflecting ongoing ...
AstraZeneca (AZN) stock is trading at GBX11,976 after a modest decline in the latest session. It sits below its key moving averages, reflecting a broadly negative ...
AstraZeneca (AZN) stock is trading at GBX12,024, reflecting a daily rise of 1.11%. The current price is situated below its key moving averages on short-term timeframes ...
AstraZeneca (AZN) stock is trading at GBX11,902, having closed lower by 2.28% for the session. The price sits below its key moving averages, reflecting downward pressure ...
AstraZeneca (AZN) stock is trading at GBX12,166, up 1.74% for the day. The price is currently positioned above its key moving averages, reflecting near-term ...
AstraZeneca (AZN) stock is trading at GBX11,924 after rising 1.36% on the day, recovering some ground but remaining below its key moving averages, which highlights ...
AstraZeneca (AZN) stock is trading at GBX11,738 after slipping 1.11% for the session. The shares remain below key short- and long-term moving averages, reflecting ...
AstraZeneca (AZN) stock is trading at GBX11,848, down 1.53% for the day. The price remains below its key moving averages, indicating ongoing short-term and long-term ...
AstraZeneca (AZN) stock is trading at GBX12,054, closing down 1.84% on the day after a gap lower and ending near its intraday lows. The shares remain under pressure, ...
Kura Oncology is drawing renewed investor attention as it shifts further into the commercial stage with an approved leukemia treatment and a broader oncology pipeline. JPMorgan says early sales ...